Kalvista Pharmaceuticals

World Rank (Jan-05-2024)

13,685

Market Cap (Jan-05-2024)

0.419 Billion USD

World Rank (Jul-30-2023)

15,237

Market Cap (Jul-30-2023)

0.335 Billion USD

World Rank (Jan-07-2022)

16,224

Market Cap (Jan-07-2022)

0.318 Billion USD

World Rank (Jan-01-2021)

13,075

Market Cap (Jan-01-2021)

0.341 Billion USD

Headquarters Country

USA

Nasdaq / NYSE Code

KALV

Market Cap (Mar-08-2026)

0.82

Headquarters City/State

Massachusetts

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

0 Million USD

Annual Net Income in USD

-46 Million USD

Annual Results for Period Ending

Apr-2021 ending year

Balance Sheet for Period Ending

Apr-2021 ending year

Business Sector

Company Website

KALVISTA PHARMACEUTICALS

Yahoo

Yahoo @ Nasdaq

Company Profile

KalVista Pharmaceuticals is a Pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases with significant unmet need. The company annual revenue is 12.7 million USD and 56 employees as on 2020. The headquarters is in USA.

Founded Year

2004

IPO Year

2015

Stock Exchange

Nasdaq

Nasdaq Sector

Health Care

Nasdaq Industry

Biotechnology: Pharmaceutical Preparations